Plasma Estrogen Levels Are Associated With Severity of Injury and Outcomes After Aneurysmal Subarachnoid Hemorrhage

Biological Research for Nursing

Volumn 17, Issue 5, 2015, Pages 558-566

  Crago, Elizabeth A ^a   Sherwood, Paula R ^a   Bender, Catherine ^a   Balzer, Jeffrey ^a,b   Ren, Dianxu ^a   Poloyac, Samuel M ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

delayed cerebral ischemia; estrogen; outcomes; subarachnoid hemorrhage

Indexed keywords

BIOLOGICAL MARKER; ESTRADIOL; ESTRONE;

ADULT; AGED; BLOOD; BRAIN CIRCULATION; FEMALE; HUMAN; INJURY SCALE; MALE; MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; SUBARACHNOID HEMORRHAGE;

ADULT; AGED; BIOMARKERS; CEREBROVASCULAR CIRCULATION; ESTRADIOL; ESTRONE; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; SUBARACHNOID HEMORRHAGE; TRAUMA SEVERITY INDICES;

EID: 84941125400     PISSN: 10998004     EISSN: 15524175     Source Type: Journal    
DOI: 10.1177/1099800414561632     Document Type: Article

References (40)

1. D.AbergK.JoodC.BlomstrandC.JernM.NilssonJ.IsgaardN.D.Aberg (2011). Serum IGF-I levels correlate to improvement of functional outcome after ischemic stroke. Journal of Clinical Endocrinology and Metabolism, 96, E1055–E1064.
2. N.J.AlkayedI.HarukuniA.S.KimesE.D.LondonR.J.TraystmanP.D.Hurn (1998). Gender-linked brain injury in experimental stroke. Stroke, 29, 159–165.
3. A.AuriatW.C.PlahtaS.C.McGieR.YanF.Colbourne (2005). 17beta-Estradiol pretreatment reduces bleeding and brain injury after intracerebral hemorrhagic stroke in male rats. Journal of Cerebral Blood Flow and Metabolism, 25, 247–256.
4. I.AzcoitiaM.A.ArevaloA.F.De NicolaL.M.Garcia-Segura (2011). Neuroprotective actions of estradiol revisited. Trends in Endocrinology and Metabolism, 22, 467–473.
5. S.BendelT.KoivistoO.P.RyynanenE.RuokonenJ.RomppanenV.KiviniemiA.Uusaro (2010). Insulin like growth factor-I in acute subarachnoid hemorrhage: A prospective cohort study. Critical Care, 14, R75.
6. M.BondanelliM.R.AmbrosioA.OnofriA.BergonzoniS.LavezziM.C.ZatelliE.C.degli Uberti (2006). Predictive value of circulating insulin-like growth factor I levels in ischemic stroke outcome. Journal of Clinical Endocrinology and Metabolism, 91, 3928–3934.
7. R.D.Brinton (2008). The healthy cell bias of estrogen action: Mitochondrial bioenergetics and neurological implications. Trends in Neuroscience, 31, 529–537.
8. C.M.BrownS.SuzukiK.A.JelksP.M.Wise (2009). Estradiol is a potent protective, restorative, and trophic factor after brain injury. Seminars in Reproductive Medicine, 27, 240–249.
9. J.CahillJ.H.Zhang (2009). Subarachnoid hemorrhage: Is it time for a new direction?Stroke, 40, S86–S87.
10. B.CanerJ.HouO.AltayM.Fuj2ndJ.H.Zhang (2012). Transition of research focus from vasospasm to early brain injury after subarachnoid hemorrhage. Journal of Neurochemistry, 123, 12–21.
11. E.A.CragoB.P.ThampattyP.R.SherwoodC.W.KuoC.BenderJ.BalzerS.M.Poloyac (2011). Cerebrospinal fluid 20-HETE is associated with delayed cerebral ischemia and poor outcomes after aneurysmal subarachnoid hemorrhage. Stroke, 42, 1872–1877.
12. N.K.de RooijG.J.RinkelJ.W.DankbaarC.J.Frijns (2013). Delayed cerebral ischemia after subarachnoid hemorrhage: A systematic review of clinical, laboratory, and radiological predictors. Stroke, 44, 43–54.
13. J.A.GarringerC.NiyonkuruE.H.McCulloughT.LoucksC.E.DixonY.P.ConleyA.K.Wagner (2013). Impact of aromatase genetic variation on hormone levels and global outcome after severe TBI. Journal of Neurotrauma, 30, 1415–1425.
14. J.W.GatsonM.M.LiuK.AbdelfattahJ.G.WiggintonS.SmithS.WolfJ.P.Minei (2012). Estrone is neuroprotective in rats after traumatic brain injury. Journal of Neurotrauma, 29, 2209–2219.
15. P.S.HersonI.P.KoernerP.D.Hurn (2009). Sex, sex steroids, and brain injury. Seminars in Reproductive Medicine, 27, 229–239.
16. P.D.HurnL.M.Brass (2003). Estrogen and stroke: A balanced analysis. Stroke, 34, 338–341.
17. S.P.JohnsenH.H.HundborgH.T.SorensenH.OrskovA.TjonnelandK.OvervadJ.O.Jorgensen (2005). Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke. Journal of Clinical Endocrinology and Metabolism, 90, 5937–5941.
18. R.M.KauffmannP.R.NorrisJ.M.JenkinsW.D.DupontR.E.TorresJ.D.BlumeA.K.May (2011). Trends in estradiol during critical illness are associated with mortality independent of admission estradiol. Journal of the American College of Surgeons, 212, 703–712.
19. E.LerchbaumS.PilzT.B.GrammerB.O.BoehmW.MarzB.Obermayer-Pietsch (2011). High estradiol levels are associated with increased mortality in older men referred to coronary angiography. Experimental and Clinical Endocrinology & Diabetes, 119, 490–496.
20. C.L.LinA.S.DumontY.F.SuY.J.TsaiJ.H.HuangK.P.ChangC.H.Kao (2009). Attenuation of cerebral vasospasm and secondary injury by 17beta-estradiol following experimental subarachnoid hemorrhage. Journal of Neurosurgery, 110, 457–461.
21. M.LiuS.DziennisP.D.HurnN.J.Alkayed (2009). Mechanisms of gender-linked ischemic brain injury. Restorative Neurology and Neuroscience, 27, 163–179.
22. J.MaS.HuangL.MaY.LiuH.LiC.You (2012). Endothelin-receptor antagonists for aneurysmal subarachnoid hemorrhage: An updated meta-analysis of randomized controlled trials. Critical Care, 16, R198.
23. A.K.MayL.A.DossettP.R.NorrisE.N.HansenR.C.DorsettK.A.PopovskyR.G.Sawyer (2008). Estradiol is associated with mortality in critically ill trauma and surgical patients. Critical Care Medicine, 36, 62–68.
24. I.N.MillerA.Cronin-Golomb (2010). Gender differences in Parkinson’s disease: Clinical characteristics and cognition. Movement Disorders, 25, 2695–2703.
25. R.E.NelsonS.K.GrebeD.J.O’KaneR.J.Singh (2004). Liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of estradiol and estrone in human plasma. Clinical Chemistry, 50, 373–384.
26. T.PappaK.VemmosE.MantzouP.SavvariK.StamatelopoulosM.Alevizaki (2012). Estradiol levels predict short-term adverse health outcomes in postmenopausal acute stroke women. European Journal of Neurology, 19, 1300–1304.
27. M.B.RauschembergerM.J.SandovalV.L.Massheimer (2011). Cellular and molecular actions displayed by estrone on vascular endothelium. Molecular and Cellular Endocrinology, 339, 136–143.
28. M.S.RothmanN.E.CarlsonM.XuC.WangR.SwerdloffP.LeeM.E.Wierman (2011). Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography-tandem mass spectrometry. Steroids, 76, 177–182.
29. S.Sealy-JeffersonJ.J.WingB.N.SanchezD.L.BrownW.J.MeurerM.A.SmithL.D.Lisabeth (2012). Age- and ethnic-specific sex differences in stroke risk. Gender Medicine, 9, 121–128.
30. F.A.SehbaJ.HouR.M.PlutaJ.H.Zhang (2012). The importance of early brain injury after subarachnoid hemorrhage. Progress in Neurobiology, 97, 14–37.
31. F.A.SehbaR.M.PlutaJ.H.Zhang (2011). Metamorphosis of subarachnoid hemorrhage research: From delayed vasospasm to early brain injury. Molecular Neurobiology, 43, 27–40.
32. J.SellesN.PoliniC.AlvarezV.Massheimer (2005). Novel action of estrone on vascular tissue: Regulation of NOS and COX activity. Steroids, 70, 251–256.
33. D.I.SprattJ.R.MortonR.S.KramerS.W.MayoC.LongcopeC.P.Vary (2006). Increases in serum estrogen levels during major illness are caused by increased peripheral aromatization. American Journal of Physiology, Endocrinology and Metabolism, 291, E631–E638.
34. M.D.VergouwenA.AlgraG.J.Rinkel (2012). Endothelin receptor antagonists for aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis update. Stroke, 43, 2671–2676.
35. M.D.VergouwenM.VermeulenY.B.Roos (2009). Delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: Is angiographic vasospasm an epiphenomenon?Stroke, 40, e39.
36. A.K.WagnerE.H.McCulloughC.NiyonkuruH.OzawaT.L.LoucksJ.A.DobosA.Fabio (2011). Acute serum hormone levels: Characterization and prognosis after severe traumatic brain injury. Journal of Neurotrauma, 28, 871–888.
37. X.XuJ.M.RomanH.J.IssaqL.K.KeeferT.D.VeenstraR.G.Ziegler (2007). Quantitative measurement of endogenous estrogens and estrogen metabolites in human serum by liquid chromatography-tandem mass spectrometry. Analytical Chemistry, 79, 7813–7821.
38. K.D.YiE.PerezS.YangR.LiuD.F.CoveyJ.W.Simpkins (2011). The assessment of non-feminizing estrogens for use in neuroprotection. Brain Research, 1379, 61–70.
39. W.ZhangJ.J.IliffC.J.CampbellR.K.WangP.D.HurnN.J.Alkayed (2009). Role of soluble epoxide hydrolase in the sex-specific vascular response to cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism, 29, 1475–1481.
40. A.Y.ZubkovA.A.Rabinstein (2009). Medical management of cerebral vasospasm: Present and future. Neurological Research, 31, 626–631.